If you’re a newly established compounding pharmacist or veterinary professional in Dubai, you’re entering a rapidly evolving market—one where offering high-quality, trusted solutions sets you apart from the competition. Among the most exciting developments in veterinary pharmaceuticals is GS‑441524, a powerful antiviral agent best known for its game-changing success in treating feline infectious peritonitis (FIP). Once considered untreatable, FIP now has a promising solution with reported remission rates of over 80%, including in advanced and neurological cases. As pet ownership rises and breeding populations grow across the UAE, the demand for effective, evidence-based treatments continues to climb. GS‑441524 represents more than just an API—it’s an opportunity to elevate your professional profile and deliver care that truly makes a difference.

MedicaPharma, based in the Netherlands and licensed by the Dutch Ministry of Health, offers GS‑441524 in its pure, GMP-grade form. The company serves medical professionals and compounding pharmacies across Europe and globally, and now offers direct access to Dubai’s rapidly growing veterinary market. With regulatory frameworks in Dubai allowing for the import of GMP-compliant raw materials under veterinary exemption or cascade protocols, this antiviral agent is now accessible for use in compliant compounding. MedicaPharma is one of the few companies that sources exclusively from certified GMP manufacturers, ensuring full documentation, including Certificates of Analysis, stability data, and safety documentation—all shipped under strict GDP conditions. This level of quality assurance not only protects your compounding pharmacy’s reputation but also ensures the confidence of the veterinary professionals and pet owners
you serve.

Download GMP-Certified API Product List

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations. Click here to download our complete API product list.

Trusted Science, Real-World Impact

GS‑441524 is a nucleoside analog and the primary active metabolite of remdesivir. In preclinical and veterinary studies, its antiviral mechanism targets viral replication by interrupting the function of RNA-dependent RNA polymerase. Though initially developed in the context of human coronaviruses, including COVID-19, its most compelling success has emerged in the veterinary world—particularly in treating FIP, a fatal disease that affects many cats, especially in high-density breeding environments or shelters. Its favorable safety profile, long half-life, and simplified synthesis make it not only clinically effective but also practical for compounding pharmacy teams looking to deliver reliable compounded medications. For veterinarians, the ability to access a GMP-certified, well-documented API provides peace of mind. For compounding pharmacists, it’s a high-impact product that reflects well on both your technical capabilities and your business acumen.

The science is important, but what makes GS‑441524 even more powerful is how it meets the real-world needs of veterinary clinics and compounding pharmacies. With a 12-month shelf life and stability in Dubai’s ambient temperatures, it’s suitable for local conditions. The flexibility to formulate it into injectable or oral dosage forms depending on clinical needs makes it adaptable across multiple use cases. Most importantly, the success stories are growing. Across Europe and Australia, compounders are already supplying GS‑441524
under veterinary exemptions, and many report consistent demand from licensed
veterinarians treating cats diagnosed with FIP. By making it available locally through a GMP-backed supplier, you offer Dubai’s veterinary community a more affordable, traceable, and safer alternative to gray market products, which often come with serious risks of contamination, adulteration, or inconsistent dosing.

A European Supplier You Can Count On

MedicaPharma is not just a distributor—it’s a specialized partner for licensed professionals who need safe, consistent access to high-quality APIs. Headquartered in the Netherlands and licensed by the Dutch Health and Youth Care Inspectorate, the company is uniquely positioned to supply hard-to-source active ingredients like GS‑441524 for legal use under veterinary exemption laws. What makes MedicaPharma particularly valuable for Dubai’s pharmaceutical and veterinary sector is its rigorous approach to sourcing and documentation. The company works only with certified GMP manufacturers—over 400 worldwide—and does not repackage or relabel. This ensures that every batch you receive
comes directly from the source, with full traceability and accountability.

For compounding pharmacies in Dubai, the logistics are just as important as the product. MedicaPharma supports its clients with complete documentation, including Certificates of Analysis, SDS, and import-ready shipping manifests. Their APIs are shipped under GDP (Good Distribution Practice) conditions with temperature monitoring, tamper-evident packaging, and chain-of-custody records. Orders from Dubai are fulfilled within two to three business days, offering both speed and security. The company also provides tailored support for regulatory filings, customs clearance, and technical questions related to compounding or stability—making them not only a supplier but a strategic partner in your operational success. As a growing **compounding pharmacy** or compounding lab, this support can be critical in helping you move quickly and compliantly into a new product category.

Lead the Future of Veterinary Antivirals in Dubai

Stocking GS‑441524 isn’t just about having a popular product—it’s about delivering meaningful, trusted care that can set your compounding pharmacy apart in a competitive marketplace. Veterinary professionals are looking for reliable partners who understand the importance of quality, documentation, and clinical outcomes. Pet owners are increasingly aware of treatment options and expect their compounding pharmacies and veterinarians to offer credible alternatives backed by science. With GS‑441524 from MedicaPharma, you offer all of that—plus the confidence that comes from dealing with a transparent,  egulated, and highly experienced European supplier.

Whether you’re just launching your compounding pharmacy or looking to expand into veterinary compounding, this is the right time to invest in a solution that’s both high-impact and low-risk. GS‑441524 is already widely used by veterinarians across Europe and Australia, and Dubai’s unique combination of advanced logistics, international clientele, and progressive regulation makes it an ideal market for early adopters. By partnering with MedicaPharma, you gain access to premium-quality raw material, backed by full regulatory documentation and expert support. More importantly, you offer a treatment that improves—
and often saves—the lives of animals in need.

To begin your order or speak with a technical advisor, visit MedicaPharma’s website and request a GS‑441524 quotation. With trusted supply, fast shipping, and full regulatory documentation, you’re one step away from becoming a leader in veterinary antiviral care in Dubai.